BioSpace News Archive

On February 7, 2019, at 07:00am CET, Calliditas Therapeutics will publish its business update for the full-year 2018.

Achieves revenue growth in Q4 of 9% on a reported basis and 10% on an organic basis, driven by CAG Diagnostics recurring revenue growth of 12% reported and 13% organic

Fourth-Quarter 2018 Worldwide Sales Were $11.0 Billion, an Increase of 5 Percent, Including a 3 Percent Negative Impact from Foreign Exchange; Full-Year 2018 Worldwide Sales Were $42.3 Billion, an Increase of 5 Percent, Including a Minimal Impact from Foreign Exchange

Positive study results may lead to the approval of the first drug to benefit a key symptom of Rett syndrome, a severe neuro-developmental orphan disease

Agreement Enhances Commercial Presence in Organ Transplant Centers

On January 26 and 27, 2019 Nova Medical Centers, the nation’s leading pure occupational medicine provider, held its second annual Providers Summit in Houston, TX.

PolarityTE, Inc. (Nasdaq: PTE) announced today that new data on the preclinical and clinical use of its SkinTE™ product, a first-of-its-kind autologous, homologous human cellular and tissue-based product designed to regenerate full-thickness, functional skin for skin repair, reconstruction and replacement, will be presented at the 41st Annual Boswick Burn and Wound Symposium, February 2-7, 2019.

Bausch Health Companies Inc. (NYSE/TSX: BHC) today announced that the Company will participate in two investor conferences in February and March

Sangamo Therapeutics, Inc. announced that management will host a conference call on February 7th at 12:30 p.m. Eastern Time.

To celebrate American Heart Month, Dr. Amy Doneen, DNP, ARNP will present a free one-hour webinar titled, “Women and Our Hearts: A Message of Reality and Hope.”